G1 Therapeutics, Inc.
CDK inhibitors
Last updated:
Abstract:
Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Status:
Grant
Type:
Utility
Filling date:
19 Dec 2018
Issue date:
30 Jun 2020